4880 — CellSource Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapFalling Star

Annual income statement for CellSource Co, fiscal year end - October 31st, JPY millions except per share, conversion factor applied.

	2020 October 31st	2021 October 31st	2022 October 31st	2023 October 31st	2024 October 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,855	2,922	4,274	4,511	4,355
Cost of Revenue
Gross Profit	1,259	2,074	3,064	3,185	2,417
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,440	1,930	2,712	3,280	4,214
Operating Profit	416	992	1,562	1,230	141
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	413	1,006	1,584	1,240	295
Provision for Income Taxes
Net Income After Taxes	274	651	1,018	923	238
Net Income Before Extraordinary Items
Net Income	274	651	1,018	923	238
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	274	651	1,018	923	238
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	14.3	33.9	53.3	47.6	11.3
Dividends per Share
Special Dividends per Share